{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:23:57Z","timestamp":1773465837038,"version":"3.50.1"},"reference-count":27,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"BioMarin Pharmaceuticals, Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.1080\/13696998.2022.2102779","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T14:10:05Z","timestamp":1658153405000},"page":"984-992","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Early real-world experience with emicizumab and concomitant factor VIII replacement products in adult males with Hemophilia A without inhibitors"],"prefix":"10.1080","volume":"25","author":[{"given":"Lorraine","family":"Cafuir","sequence":"first","affiliation":[{"name":"Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA"},{"name":"Hemophilia of Georgia Center for Bleeding &amp; Clotting Disorders of Emory, Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8866-2911","authenticated-orcid":false,"given":"Adina","family":"Estrin","sequence":"additional","affiliation":[{"name":"Scientific Engagement, Aetion, Inc, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Er","family":"Chen","sequence":"additional","affiliation":[{"name":"BioMarin Pharmaceuticals, Inc, San Rafael, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0219-9941","authenticated-orcid":false,"given":"David","family":"Hinds","sequence":"additional","affiliation":[{"name":"BioMarin Pharmaceuticals, Inc, San Rafael, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0705-6942","authenticated-orcid":false,"given":"Patricia","family":"Prince","sequence":"additional","affiliation":[{"name":"Scientific Engagement, Aetion, Inc, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2417-610X","authenticated-orcid":false,"given":"Jennifer","family":"Thorburn","sequence":"additional","affiliation":[{"name":"Scientific Engagement, Aetion, Inc, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6599-7142","authenticated-orcid":false,"given":"Henry","family":"Mead","sequence":"additional","affiliation":[{"name":"BioMarin Pharmaceuticals, Inc, San Rafael, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2391-2016","authenticated-orcid":false,"given":"Christine L.","family":"Kempton","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA"},{"name":"Hemophilia of Georgia Center for Bleeding &amp; Clotting Disorders of Emory, Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,8]]},"reference":[{"key":"e_1_3_4_2_1","unstructured":"Hemophilia A. Genetic and Rare Diseases Information Center (GARD) \u2013 an NCATS Program [Internet]. [cited 2021 Jun 17]. Available from: https:\/\/rarediseases.info.nih.gov\/diseases\/6591\/hemophilia-a"},{"key":"e_1_3_4_3_1","unstructured":"Hemophilia A. [Internet]. National Hemophilia Foundation. [cited 2021 Jun 17]. Available from: https:\/\/www.hemophilia.org\/bleeding-disorders-a-z\/types\/hemophilia-a."},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14046"},{"key":"e_1_3_4_5_1","unstructured":"Research C for DE and FDA approves emicizumab-kxwh for prevention and reduction of bleeding in patients with hemophilia A with factor VIII inhibitors. FDA [Internet]. 2019. [cited 2021 Oct 13]; Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-emicizumab-kxwh-prevention-and-reduction-bleeding-patients-hemophilia-factor-viii."},{"key":"e_1_3_4_6_1","unstructured":"Research C for DE and FDA approves emicizumab-kxwh for hemophilia A with or without factor VIII inhibitors. FDA [Internet]. 2019. [cited 2021 Oct 13]; Available from: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/fda-approves-emicizumab-kxwh-hemophilia-or-without-factor-viii-inhibitors."},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13758"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2015.1016228"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13220"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14005"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14318"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10194303"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-139568"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-137632"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14347"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14261"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12571"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009217"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14363"},{"key":"e_1_3_4_20_1","first-page":"316","volume-title":"J Manag Care Spec Pharm","author":"Croteau SE","year":"2021","unstructured":"Croteau SE, Cook K, Sheikh L, et\u00a0al. Health care resource utilization and costs among adult patients with hemophilia A on factor VIII prophylaxis: an administrative claims analysis. J Manag Care Spec Pharm. 2021;27(3):316\u2013326."},{"key":"e_1_3_4_21_1","unstructured":"IBM MarketScan Research Databases for Life Sciences Researchers. 2021."},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2021.21368"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045343"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2021-0109"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.03.008"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1703068"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001869"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30054-7"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2022.2102779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T11:13:41Z","timestamp":1729163621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2022.2102779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1080\/13696998.2022.2102779"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2022.2102779","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-05-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}